Author Archives: donttradeourlivesaway

TPP Negotiations Lack ‘Oversight And Scrutiny,’ Australian Parliament Report Reveals

Source: HNGN 30 June 2015 The “Blind Agreement” report says that because lawmakers are only allowed to officially review trade laws once they have officially passed, “Parliament is faced with an all-or-nothing choice” on whether to approve the accord. An … Continue reading

Posted in Trans-Pacific Partnership Agreement | Leave a comment

EU, India aim to resume stalled FTA talks in August

Source: Livemint 30 June 2015 Commerce secretary says this is the best time to conclude the deal to give a boost to textile and leather exports New Delhi: Despite the ongoing turmoil in the euro zone over Greece’s debt crisis, … Continue reading

Posted in EU-India FTA, TRIPS plus | Leave a comment

Pressure intensifies on India over software and pharma patent protection in key Asian trade negotiations

Source: I Am 23 June 2015 The proposed Trans-Pacific Partnership (TPP) has grabbed its fair share of headlines in both Asia and the Americas after the US House of Representatives’ dramatic rejection of a key part of the package. But … Continue reading

Posted in Compulsory Licensing, Non violation complaints, Regional Comprehensive Economic Partnership, Sec 3 (d), Trans-Pacific Partnership Agreement, TRIPS plus | Leave a comment

The Effects of TRIPS-Plus IP Provisions on Access to Affordable Medicines

Source: Infojustice 19 June 2015 The effects of patenting pharmaceutical products on access to medicines in developing countries are relatively recent as these countries have only been mandated by the World Trade Organization (WTO) Agreement on Trade-Related Aspects of Intellectual … Continue reading

Posted in FTAs, TPPA, TRIPS, TRIPS flexibilities, TRIPS plus | Leave a comment

China rejects Gilead hepatitis C drug patent -advocacy group

Source: Reuters 19 June 2015 China has rejected Gilead Sciences Inc’s application for a new patent related to its costly hepatitis C drug Sovaldi, removing a potential barrier to generic versions of the drug there, a U.S. legal group announced … Continue reading

Posted in Hepatitis - C, Patent Opposition | Leave a comment

Drug prices too high? Many blame pharma companies

Source: CNBC 19 June 2015 Drug companies are going to need to take an aspirin—or three—after reading this. A new poll finds that most Americans see drug prices as being unreasonably high—and that people are far more likely to blame … Continue reading

Posted in Drug Pricing | Leave a comment

House Rejects Trade Measure, Rebuffing Obama’s Dramatic Appeal

Source: The New York Times 15 June 2015 WASHINGTON — Hours after President Obama made a dramatic, personal appeal for support, House Democrats on Friday thwarted his push to expand trade negotiating power — and quite likely his chance to … Continue reading

Posted in FTAs, Trans-Pacific Partnership Agreement | Leave a comment